Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - tick-borne encephalitis virus (inactivated) neudoerfl - suspension for injection in pre-filled syringe - 0.25 millilitre(s) - encephalitis vaccines; encephalitis, tick borne, inactivated, whole virus - encephalitis vaccines - it is indicated for the active (prophylactic) immunization of children aged from 1 year to 15 years against tick-borne encephalitis (tbe).

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - tbe virus antigen - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - encephalitis vaccines; encephalitis, tick borne, inactivated, whole virus - encephalitis vaccines - it is indicated for the active (prophylactic) immunization of persons of 16 years of age and older against tick-borne encephalitis (tbe).

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter vaccine ag - tbe virus antigen - suspension for injection - %v/v

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter vaccine ag - tbe virus antigen - suspension for injection - %v/v

Malta - English - Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - tick, borne encephalitis, virus - suspension for injection - tick-borne encephalitis virus 1,2 - vaccines

Malta - English - Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - tick, borne encephalitis, virus - suspension for injection in pre-filled syringe - tick-borne encephalitis virus 1,2 0.5 ml - vaccines

European Union - English - EMA (European Medicines Agency)

allergan pharmaceuticals ireland - bimatoprost, timolol - glaucoma, open-angle, ocular hypertension - ophthalmologicals, - reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

European Union - English - EMA (European Medicines Agency)

ipsen pharma - mecasermin - laron syndrome - pituitary and hypothalamic hormones and analogues - for the long-term treatment of growth failure in children and adolescents with severe primary insulin-like-growth-factor-1 deficiency (primary igfd).severe primary igfd is defined by:height standard deviation score ≤ -3.0 and;basal insulin-like growth factor-1 (igf-1) levels below the 2.5th percentile for age and gender and;growth hormone (gh) sufficiency;exclusion of secondary forms of igf-1 deficiency, such as malnutrition, hypothyroidism, or chronic treatment with pharmacologic doses of anti-inflammatory steroids.severe primary igfd includes patients with mutations in the gh receptor (ghr), post-ghr signalling pathway, and igf-1 gene defects; they are not gh deficient, and therefore, they cannot be expected to respond adequately to exogenous gh treatment. it is recommended to confirm the diagnosis by conducting an igf-1 generation test.

European Union - English - EMA (European Medicines Agency)

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

jd healthcare group pty ltd - 63241 - alternating-pressure bed mattress system - the turn all? system turns a standard bed into an automated lateral turning bed. the system is to support clinicians and carers in the regular turning of primary immobile patients, who are at the highest risk of developing pressure ulcers. the system offers comprehensive pressure relief, prevention of pressure injuries/ulcers and aids in the treatment of existing injuries/ulcers to patients.